RATIONALE: Activation of the mitochondrial ATP-sensitive potassium channel (mitoK(ATP)) has been implicated in the mechanism of cardiac ischemic preconditioning, yet its molecular composition is unknown. OBJECTIVE: To use an unbiased proteomic analysis of the mitochondrial inner membrane to identify the mitochondrial K(+) channel underlying mitoK(ATP). METHODS AND RESULTS: Mass spectrometric analysis was used to identify KCNJ1(ROMK) in purified bovine heart mitochondrial inner membrane and ROMK mRNA was confirmed to be present in neonatal rat ventricular myocytes and adult hearts. ROMK2, a short form of the channel, is shown to contain an N-terminal mitochondrial targeting signal, and a full-length epitope-tagged ROMK2 colocalizes with mitochondrial ATP synthase β. The high-affinity ROMK toxin, tertiapin Q, inhibits mitoK(ATP) activity in isolated mitochondria and in digitonin-permeabilized cells. Moreover, short hairpin RNA-mediated knockdown of ROMK inhibits the ATP-sensitive, diazoxide-activated component of mitochondrial thallium uptake. Finally, the heart-derived cell line, H9C2, is protected from cell death stimuli by stable ROMK2 overexpression, whereas knockdown of the native ROMK exacerbates cell death. CONCLUSIONS: The findings support ROMK as the pore-forming subunit of the cytoprotective mitoK(ATP) channel.
RATIONALE: Activation of the mitochondrial ATP-sensitive potassium channel (mitoK(ATP)) has been implicated in the mechanism of cardiac ischemic preconditioning, yet its molecular composition is unknown. OBJECTIVE: To use an unbiased proteomic analysis of the mitochondrial inner membrane to identify the mitochondrial K(+) channel underlying mitoK(ATP). METHODS AND RESULTS: Mass spectrometric analysis was used to identify KCNJ1(ROMK) in purified bovine heart mitochondrial inner membrane and ROMK mRNA was confirmed to be present in neonatal rat ventricular myocytes and adult hearts. ROMK2, a short form of the channel, is shown to contain an N-terminal mitochondrial targeting signal, and a full-length epitope-tagged ROMK2 colocalizes with mitochondrial ATP synthase β. The high-affinity ROMK toxin, tertiapin Q, inhibits mitoK(ATP) activity in isolated mitochondria and in digitonin-permeabilized cells. Moreover, short hairpin RNA-mediated knockdown of ROMK inhibits the ATP-sensitive, diazoxide-activated component of mitochondrial thallium uptake. Finally, the heart-derived cell line, H9C2, is protected from cell death stimuli by stable ROMK2 overexpression, whereas knockdown of the native ROMK exacerbates cell death. CONCLUSIONS: The findings support ROMK as the pore-forming subunit of the cytoprotective mitoK(ATP) channel.
Authors: Grazyna Debska; Anna Kicinska; Jolanta Skalska; Adam Szewczyk; Rebecca May; Christian E Elger; Wolfram S Kunz Journal: Biochim Biophys Acta Date: 2002-12-02
Authors: Matthew C Henn; M Burhan Janjua; Haixia Zhang; Evelyn M Kanter; Carol M Makepeace; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton Journal: J Am Coll Surg Date: 2015-02-21 Impact factor: 6.113
Authors: Renata Toczyłowska-Mamińska; Anna Olszewska; Michał Laskowski; Piotr Bednarczyk; Krzysztof Skowronek; Adam Szewczyk Journal: J Invest Dermatol Date: 2013-10-14 Impact factor: 8.551
Authors: Sergey M Korotkov; Irina V Brailovskaya; Anton R Shumakov; Larisa V Emelyanova Journal: J Bioenerg Biomembr Date: 2015-04-14 Impact factor: 2.945
Authors: Prasad V G Katakam; Edina A Wappler; Paige S Katz; Ibolya Rutkai; Adam Institoris; Ferenc Domoki; Tamás Gáspár; Samuel M Grovenburg; James A Snipes; David W Busija Journal: Arterioscler Thromb Vasc Biol Date: 2013-01-17 Impact factor: 8.311
Authors: Andrew P Wojtovich; William R Urciuoli; Shampa Chatterjee; Aron B Fisher; Keith Nehrke; Paul S Brookes Journal: Am J Physiol Heart Circ Physiol Date: 2013-04-12 Impact factor: 4.733
Authors: Melissa M Anastacio; Evelyn M Kanter; Angela D Keith; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton Journal: J Am Coll Surg Date: 2013-03-25 Impact factor: 6.113